Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kölsch

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Archives of Women'S Mental Health|January 3, 2003
Neuroprotective effects of estradiol-17beta: implications for psychiatric disordersH Kölsch, M L Rao
Psychoneuroendocrinology|March 26, 2003
Effects of estrogen on brain development and neuroprotection--implications for negative symptoms in schizophreniaM L Rao, H Kölsch
The Journal of Nutrition, Health & Aging|April 8, 2003
The role of 24S-hydroxycholesterol in Alzheimer's diseaseH Kölsch, D Lütjohann, K von Bergmann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 28, 2001
Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17betaH Kölsch, M Ludwig, D Lütjohann, et al.
Brain Research|January 23, 1999
The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cellsH Kölsch, D Lütjohann, A Tulke, et al.
Neurochemistry International|April 13, 2000
7alpha-Hydroperoxycholesterol causes CNS neuronal cell deathH Kölsch, M Ludwig, D Lütjohann, et al.
Neuroscience Letters|September 15, 2004
Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patientsH Kölsch, R Heun, A Kerksiek, et al.
Neuroscience Letters|February 22, 2005
ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementiaH Kölsch, F Jessen, N Freymann, et al.
Neuroscience Letters|May 30, 2006
Influence of lysosomal acid lipase polymorphisms on chromosome 10 on the risk of Alzheimer's disease and cholesterol metabolismK-T von Trotha, R Heun, S Schmitz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 17, 2005
Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer's diseaseH Kölsch, D Lütjohann, F Jessen, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Archives of Women'S Mental Health|January 3, 2003
Neuroprotective effects of estradiol-17beta: implications for psychiatric disordersH Kölsch, M L Rao
Psychoneuroendocrinology|March 26, 2003
Effects of estrogen on brain development and neuroprotection--implications for negative symptoms in schizophreniaM L Rao, H Kölsch
The Journal of Nutrition, Health & Aging|April 8, 2003
The role of 24S-hydroxycholesterol in Alzheimer's diseaseH Kölsch, D Lütjohann, K von Bergmann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 28, 2001
Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17betaH Kölsch, M Ludwig, D Lütjohann, et al.
Brain Research|January 23, 1999
The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cellsH Kölsch, D Lütjohann, A Tulke, et al.
Neurochemistry International|April 13, 2000
7alpha-Hydroperoxycholesterol causes CNS neuronal cell deathH Kölsch, M Ludwig, D Lütjohann, et al.
Neuroscience Letters|September 15, 2004
Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patientsH Kölsch, R Heun, A Kerksiek, et al.
Neuroscience Letters|February 22, 2005
ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementiaH Kölsch, F Jessen, N Freymann, et al.
Neuroscience Letters|May 30, 2006
Influence of lysosomal acid lipase polymorphisms on chromosome 10 on the risk of Alzheimer's disease and cholesterol metabolismK-T von Trotha, R Heun, S Schmitz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 17, 2005
Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer's diseaseH Kölsch, D Lütjohann, F Jessen, et al.
Pageof 3